
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [NBIX] Neurocrine Biosciences Inc
Data updated 2025-May-12 (Monday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-May-12 Monday
Open | $116.21 | High | $120.87 +4.01% |
---|---|---|---|
Close | $120.43 | Low | $116.01 -0.17% |
Volume | 1.69 Million 1.33x | Volatility | 4.19% |
Change |
+$4.72
+4.08%
|
Streak | ↑ 1 days +4.08% |
20d SMA | $107.61 +11.9% | 50d SMA | $107.51 +12.0% | 100d SMA | $121.26 -0.7% | 200d SMA | $124.33 -3.1% |
RSI | 66 | MACD | 1.94 | ADX | 33.2 | Stochastic Oscillator | 58.3 61.3 |
CCI | 121.9 | ATR | 5.09 | OBV | 60.2 Million | Chaikin A/D | 37.3 Million |
Market Cap | 13.8 B | PEG Ratio | 0.46 | Trailing P/E | 56.2 | Forward P/E | 27 |
Price/Sales (ttm) | 7.44 | Price/Book (mrq) | 6.19 | EV/Revenue (ttm) | 7.01 | EV/EBITDA (ttm) | 36.9 |
% Held by Insiders | 1.00% | % Held by Institutions | 95.36% | Shares Short | 2.48 M | Shares Short (prior month) | 2.18 M |
Short Ratio | 2.72 | Short % of Outstanding | 2.49% | Short % of Float | 2.53% | Shares Short Change (mom) | +13.8% |
Revenue/Share (ttm) | $19.32 | Profit Margin (ttm) | 13.23% | Operating Margin (ttm) | 29.17% | EBITDA (ttm) | 416 M |
Diluted EPS (ttm) | $2.47 | Current Ratio (mrq) | 2.45 | Return on Assets (ttm) | 8.78% | Return on Equity (ttm) | 12.68% |
Qtr Earnings Growth (yoy) | 66.00% | Qtr Revenue Growth (yoy) | 25.00% | Operating Cash Flow (ttm) | 390 M | Free Cash Flow (ttm) | 405 M |
Choose view type
Monthly Performance for Neurocrine Biosciences Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Neurocrine Biosciences Inc up to close of 2025-May-12 at $120.43
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+9.73%
|
-7.7%
|
+4.1%
|
12.8%
|
+1.3%
|
|
1.33x
|
02 Trailing 10-days
|
|
+13.12%
|
-7.7%
|
+14.5%
|
24.1%
|
+6.1%
|
|
1.07x
|
03 Trailing 20-days
|
|
+32.53%
|
-7.7%
|
+30.5%
|
41.3%
|
+11.9%
|
|
1.15x
|
04 Trailing 30-days
|
|
+6.42%
|
-7.7%
|
+43.0%
|
54.9%
|
+15.3%
|
|
1.16x
|
05 Trailing 50-days
|
|
+1.44%
|
-7.7%
|
+43.0%
|
54.9%
|
+12.0%
|
|
1.11x
|
06 Trailing 100-days
|
|
-4.95%
|
-22.1%
|
+43.0%
|
83.6%
|
-0.7%
|
|
1.22x
|
07 Trailing 200-days
|
|
-17.45%
|
-23.8%
|
+43.0%
|
87.6%
|
-3.1%
|
|
1.08x
|
08 Month-to-date
|
|
+11.83%
|
-7.7%
|
+14.2%
|
23.7%
|
|
|
|
09 Quarter-to-date
|
|
+8.89%
|
-7.7%
|
+43.0%
|
54.9%
|
|
|
|
10 Year-to-date
|
|
-11.77%
|
-22.1%
|
+43.0%
|
83.6%
|
|
|
|
11 Trailing 52-weeks
|
|
-11.90%
|
-23.8%
|
+43.0%
|
87.6%
|
|
|
|
5-year Performance Benchmarks for Neurocrine Biosciences Inc:
Related to Neurocrine Biosciences Inc
Information for Neurocrine Biosciences Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-12 on Google
SEC Reports : Quarterly reports around 2025-May-12 on SEC Edgar
Compare Neurocrine Biosciences Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Neurocrine Biosciences Inc
Industry : Biotechnology industry performance which includes Neurocrine Biosciences Inc